ANZUPGO (DELGOCITINIB)

Serial Number 79386561
Registration 7691334
700

Registration Progress

Application Filed
Oct 9, 2023
Under Examination
Approved for Publication
Dec 31, 2024
Published for Opposition
Dec 31, 2024
Registered
Feb 18, 2025

Trademark Image

ANZUPGO (DELGOCITINIB)

Basic Information

Serial Number
79386561
Registration Number
7691334
Filing Date
October 9, 2023
Registration Date
February 18, 2025
Published for Opposition
December 31, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 18, 2025
Registration
Registered
Classes
005 038 042 044

Rights Holder

LEO Pharma A/S

84
Address
Industriparken 55
DK-2750 Ballerup
DK

Ownership History

LEO Pharma A/S

Original Applicant
84
DK

LEO Pharma A/S

Owner at Publication
84
DK

LEO Pharma A/S

Original Registrant
84
DK

Legal Representation

Attorney
B. Brett Heavner

USPTO Deadlines

Next Deadline
2023 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-02-18)
Due Date
February 18, 2031
Grace Period Ends
August 18, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

23 events
Date Code Type Description Documents
May 18, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Mar 7, 2025 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Feb 18, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Feb 18, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 31, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 31, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 25, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 4, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 26, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 26, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 26, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 5, 2024 ATRV O ATTORNEY REVIEW COMPLETED Loading...
Oct 28, 2024 CREV I CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED Loading...
Jul 20, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
Jul 20, 2024 CRCV M CORRECTION TRANSACTION RECEIVED FROM IB Loading...
Jun 25, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jun 25, 2024 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jun 14, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
May 29, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 28, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 2, 2024 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Dec 29, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 28, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of skin diseases, including hand eczema and chronic hand eczema; the foregoing containing delgocitinib as the primary ingredient
Class 038
Providing online forums for information and communication about skin diseases, including hand eczema and chronic hand eczema
Class 042
Scientific and medical research in the field of skin diseases; pharmaceutical research and development in the field of skin diseases; scientific research for medical purposes in the field of skin diseases; medical and pharmaceutical tests of pharmaceutical preparations being testing of pharmaceuticals in the field of skin diseases; providing information and consulting services in the field of medical and scientific research and pharmaceutical products development related to skin diseases and treatment of the skin; providing scientific information and scientific consulting services in the field of science related to skin diseases and treatment of the skin
Class 044
Medical services in the field of skin diseases; medical, health and pharmaceutical consultation in the field of skin diseases

Additional Information

Design Mark
The mark consists of the black stylized wording "ANZUPGO" placed above the black stylized wording "(DELGOCITINIB)". To the left of this wording is placed a design of a green curved band.
Color Claim
The color(s) green and black is/are claimed as a feature of the mark.

Classification

International Classes
005 038 042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"DELGOCITINIB"